Literature DB >> 27893462

Biallelic mutations in IRF8 impair human NK cell maturation and function.

Emily M Mace, Venetia Bigley, Justin T Gunesch, Ivan K Chinn, Laura S Angelo, Matthew A Care, Sheetal Maisuria, Michael D Keller, Sumihito Togi, Levi B Watkin, David F LaRosa, Shalini N Jhangiani, Donna M Muzny, Asbjørg Stray-Pedersen, Zeynep Coban Akdemir, Jansen B Smith, Mayra Hernández-Sanabria, Duy T Le, Graham D Hogg, Tram N Cao, Aharon G Freud, Eva P Szymanski, Sinisa Savic, Matthew Collin, Andrew J Cant, Richard A Gibbs, Steven M Holland, Michael A Caligiuri, Keiko Ozato, Silke Paust, Gina M Doody, James R Lupski, Jordan S Orange.   

Abstract

Human NK cell deficiencies are rare yet result in severe and often fatal disease, particularly as a result of viral susceptibility. NK cells develop from hematopoietic stem cells, and few monogenic errors that specifically interrupt NK cell development have been reported. Here we have described biallelic mutations in IRF8, which encodes an interferon regulatory factor, as a cause of familial NK cell deficiency that results in fatal and severe viral disease. Compound heterozygous or homozygous mutations in IRF8 in 3 unrelated families resulted in a paucity of mature CD56dim NK cells and an increase in the frequency of the immature CD56bright NK cells, and this impairment in terminal maturation was also observed in Irf8-/-, but not Irf8+/-, mice. We then determined that impaired maturation was NK cell intrinsic, and gene expression analysis of human NK cell developmental subsets showed that multiple genes were dysregulated by IRF8 mutation. The phenotype was accompanied by deficient NK cell function and was stable over time. Together, these data indicate that human NK cells require IRF8 for development and functional maturation and that dysregulation of this function results in severe human disease, thereby emphasizing a critical role for NK cells in human antiviral defense.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27893462      PMCID: PMC5199714          DOI: 10.1172/JCI86276

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  76 in total

1.  Regulation of bifurcating B cell trajectories by mutual antagonism between transcription factors IRF4 and IRF8.

Authors:  Heping Xu; Virendra K Chaudhri; Zhiguo Wu; Konstantinos Biliouris; Krista Dienger-Stambaugh; Yrina Rochman; Harinder Singh
Journal:  Nat Immunol       Date:  2015-10-05       Impact factor: 25.606

2.  Fatal varicella associated with selective natural killer cell deficiency.

Authors:  Amos Etzioni; Celine Eidenschenk; Rina Katz; Rafeal Beck; Jean Laurent Casanova; Shimon Pollack
Journal:  J Pediatr       Date:  2005-03       Impact factor: 4.406

3.  CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity.

Authors:  Todd A Fehniger; Megan A Cooper; Gerard J Nuovo; Marina Cella; Fabio Facchetti; Marco Colonna; Michael A Caligiuri
Journal:  Blood       Date:  2002-12-12       Impact factor: 22.113

4.  Identification of an unusual Fc gamma receptor IIIa (CD16) on natural killer cells in a patient with recurrent infections.

Authors:  E de Vries; H R Koene; J M Vossen; J W Gratama; A E von dem Borne; J L Waaijer; A Haraldsson; M de Haas; M J van Tol
Journal:  Blood       Date:  1996-10-15       Impact factor: 22.113

5.  Requirement for IRF-1 in the microenvironment supporting development of natural killer cells.

Authors:  K Ogasawara; S Hida; N Azimi; Y Tagaya; T Sato; T Yokochi-Fukuda; T A Waldmann; T Taniguchi; S Taki
Journal:  Nature       Date:  1998-02-12       Impact factor: 49.962

6.  Human NK cells proliferate and die in vivo more rapidly than T cells in healthy young and elderly adults.

Authors:  Charles T Lutz; Anush Karapetyan; Ahmad Al-Attar; Brent J Shelton; Kimberly J Holt; Jason H Tucker; Steven R Presnell
Journal:  J Immunol       Date:  2011-03-14       Impact factor: 5.422

7.  PRDM1/Blimp-1 controls effector cytokine production in human NK cells.

Authors:  Matthew A Smith; Michelle Maurin; Hyun Il Cho; Brian Becknell; Aharon G Freud; Jianhua Yu; Sheng Wei; Julie Djeu; Esteban Celis; Michael A Caligiuri; Kenneth L Wright
Journal:  J Immunol       Date:  2010-10-13       Impact factor: 5.422

8.  Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset.

Authors:  Emily M Mace; Amy P Hsu; Linda Monaco-Shawver; George Makedonas; Joshua B Rosen; Lesia Dropulic; Jeffrey I Cohen; Eugene P Frenkel; John C Bagwell; John L Sullivan; Christine A Biron; Christine Spalding; Christa S Zerbe; Gulbu Uzel; Steven M Holland; Jordan S Orange
Journal:  Blood       Date:  2013-01-30       Impact factor: 22.113

9.  IFN-alpha and IL-12 activate IFN regulatory factor 1 (IRF-1), IRF-4, and IRF-8 gene expression in human NK and T cells.

Authors:  Anne Lehtonen; Riikka Lund; Riitta Lahesmaa; Ilkka Julkunen; Timo Sareneva; Sampsa Matikainen
Journal:  Cytokine       Date:  2003-11-07       Impact factor: 3.861

10.  Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses.

Authors:  Silke Paust; Harvinder S Gill; Bao-Zhong Wang; Michael P Flynn; E Ashley Moseman; Balimkiz Senman; Marian Szczepanik; Amalio Telenti; Philip W Askenase; Richard W Compans; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2010-10-24       Impact factor: 25.606

View more
  37 in total

1.  An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion.

Authors:  John D Klement; Amy V Paschall; Priscilla S Redd; Mohammed L Ibrahim; Chunwan Lu; Dafeng Yang; Esteban Celis; Scott I Abrams; Keiko Ozato; Kebin Liu
Journal:  J Clin Invest       Date:  2018-11-05       Impact factor: 14.808

Review 2.  Emerging insights into human health and NK cell biology from the study of NK cell deficiencies.

Authors:  Emily M Mace; Jordan S Orange
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

Review 3.  Human inborn errors of immunity to herpes viruses.

Authors:  Emmanuelle Jouanguy; Vivien Béziat; Trine H Mogensen; Jean-Laurent Casanova; Stuart G Tangye; Shen-Ying Zhang
Journal:  Curr Opin Immunol       Date:  2020-01-31       Impact factor: 7.486

4.  Editorial: On matters of maturity, self-control, and responsiveness: inhibitory NK receptors in the driver's seat?

Authors:  Michael G Brown; Awndre Gamache
Journal:  J Leukoc Biol       Date:  2017-12       Impact factor: 4.962

5.  Inactivating Mutation in IRF8 Promotes Osteoclast Transcriptional Programs and Increases Susceptibility to Tooth Root Resorption.

Authors:  Vivek Thumbigere-Math; Brian L Foster; Mahesh Bachu; Hiroaki Yoshii; Stephen R Brooks; Alyssa Coulter; Michael B Chavez; Sumihito Togi; Anthony L Neely; Zuoming Deng; Kim C Mansky; Keiko Ozato; Martha J Somerman
Journal:  J Bone Miner Res       Date:  2019-03-06       Impact factor: 6.741

6.  Genome-wide analyses and functional profiling of human NK cell lines.

Authors:  Justin T Gunesch; Laura S Angelo; Sanjana Mahapatra; Raquel P Deering; Johanna E Kowalko; Patrick Sleiman; John W Tobias; Linda Monaco-Shawver; Jordan S Orange; Emily M Mace
Journal:  Mol Immunol       Date:  2018-07-24       Impact factor: 4.407

Review 7.  Mutually assured destruction: the cold war between viruses and natural killer cells.

Authors:  Ayad Ali; Ivayla E Gyurova; Stephen N Waggoner
Journal:  Curr Opin Virol       Date:  2019-03-13       Impact factor: 7.090

8.  Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.

Authors:  Alexander Vargas-Hernández; Emily M Mace; Ofer Zimmerman; Christa S Zerbe; Alexandra F Freeman; Sergio Rosenzweig; Jennifer W Leiding; Troy Torgerson; Matthew C Altman; Edith Schussler; Charlotte Cunningham-Rundles; Ivan K Chinn; Alexandre F Carisey; Imelda C Hanson; Nicholas L Rider; Steven M Holland; Jordan S Orange; Lisa R Forbes
Journal:  J Allergy Clin Immunol       Date:  2017-10-27       Impact factor: 10.793

Review 9.  A research-driven approach to the identification of novel natural killer cell deficiencies affecting cytotoxic function.

Authors:  Michael T Lam; Emily M Mace; Jordan S Orange
Journal:  Blood       Date:  2020-02-27       Impact factor: 22.113

Review 10.  The Impact of Immunodeficiency on NK Cell Maturation and Function.

Authors:  Alexander Vargas-Hernández; Lisa R Forbes
Journal:  Curr Allergy Asthma Rep       Date:  2019-01-19       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.